Results 101 to 110 of about 17,035 (191)

New-onset vitiligo following proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab: A possible immune-mediated adverse effect. [PDF]

JAAD Case Rep
Umaña Mejia CA, Olvera Morales M, Jurado Orozco A, Burgos JD.   +3 more
europepmc   +1 more source

Proprotein convertase subtilisin/kexin type 9-CC-motif chemokine ligand 2 interactions link lipoprotein(a) composition to intermediate monocyte inflammation in coronary artery disease. [PDF]

Atheroscler Plus
Ugovšek S, Rehberger Likozar A, Levstek T, Trebušak Podkrajšek K, Zupan J, Marka F, Trimmel T, Brekalo M, Speidl W, Hohensinner P, Haider P, Šebeštjen M.   +11 more
europepmc   +1 more source

Efficacy and safety of proprotein convertase subtilisin/kexin type 9 inhibitors for adults with familial hypercholesterolemia: A network meta-analysis. [PDF]

Int J Cardiol Cardiovasc Risk Prev
Ding W, Sun L, Shi Y, Tian L.
europepmc   +1 more source

The chaperone GRP94 interacts with the proprotein convertase furin and regulates TGF-beta maturation in human primary M2 macrophages. [PDF]

Cell Death Discov
Baverel V, Wang F, Garrido C, Kohli E.
europepmc   +1 more source

Lipid-Lowering Efficacy and Safety of Oral Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Systematic Review and Meta-Analysis. [PDF]

Adv Ther
Masson W, Lobo M, Giunta G, Barbagelata L, Nogueira JP.   +4 more
europepmc   +1 more source

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9): The Multifaceted Biology, Diseases, and Pharmaceutical Interventions. [PDF]

MedComm (2020)
Kuang J, Hao L, Zhang M, Yang Z.
europepmc   +1 more source

Structural insights into proprotein convertase activation facilitate the engineering of highly specific furin inhibitors. [PDF]

Nat Commun
Klaushofer R, Bloch K, Eder LS, Marzaro S, Schubert M, Böttcher-Friebertshäuser E, Brandstetter H, Dahms SO.   +7 more
europepmc   +1 more source

Genetic Pathogenesis of Abdominal Aortic Aneurysm and the Role of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9). [PDF]

Vasc Specialist Int
Choi JY, Gwon JG.
europepmc   +1 more source

Substrate selectivity by proprotein convertases

Developmental Biology, 2007
Nelsen, Sylvia M., Christian, Jan L.
openaire   +1 more source

Proprotein Convertase Subtilisin/Kexin Type 9 Induces Platelet-Derived Transforming Growth Factor-<i>β</i> to Promote Myocardial Fibrosis After Myocardial Infarction. [PDF]

Hum Mutat
Wang Q, Huang W, Xia D, Wang F, Nair S.
europepmc   +1 more source